Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin

<p>Abstract</p> <p>Intravesical administration of <it>Bacillus Calmette-Guérin </it>is used as a treatment method in superficial bladder cancer. While it is generally well tolerated, serious side effects may develop. Granulomatous hepatitis cases have been previously re...

Full description

Bibliographic Details
Main Authors: Ciltas Aydin, Yasar Nurgul, Polat Hakan, Ince Ali T, Soylu Aliye, Ozkara Selvinaz, Tasci Ali I
Format: Article
Language:English
Published: BMC 2009-04-01
Series:Annals of Clinical Microbiology and Antimicrobials
Online Access:http://www.ann-clinmicrob.com/content/8/1/12
Description
Summary:<p>Abstract</p> <p>Intravesical administration of <it>Bacillus Calmette-Guérin </it>is used as a treatment method in superficial bladder cancer. While it is generally well tolerated, serious side effects may develop. Granulomatous hepatitis cases have been previously reported; however, only one case with tuberculous peritonitis exists in the current literature. We hereby present two cases, one of which is the second tubercular peritonitis case following <it>Bacillus Calmette-Guérin </it>treatment to be reported, and the other a case with granulomatous hepatitis. Complete cure was achieved in both cases with specific therapy. In the patient who developed peritonitis, intravesical <it>Bacillus Calmette-Guérin </it>therapy was recommenced after antituberculosis treatment, and completed without further complications.</p>
ISSN:1476-0711